What is a stock summary page? Click here for an overview.
Omeros Corp (NAS:OMER) Stock News, Headlines & Updates
Omeros Corp Stock News from GuruFocus
- 1
Apr 08, 2025
Omeros Corporation To Introduce Its Proprietary T-CATâ„¢ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases
Business Wire • 9:00am
Apr 01, 2025
Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with Strategic Initiatives
GuruFocus News • 1:03am
Q4 2024 Omeros Corp Earnings Call Transcript
GuruFocus News • 11:01pm
Omeros (OMER) Exceeds Q4 EPS Expectations, Reports Cash Decline
GuruFocus News • 7:55pm
Mar 31, 2025
Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results
Business Wire • 4:00pm
Mar 26, 2025
Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025
Business Wire • 9:00am
Mar 21, 2025
Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program
Business Wire • 9:00am
Mar 13, 2025
Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company's OMS527 Program to Treat Cocaine Use Disorder
Business Wire • 9:00am
Feb 23, 2025
INGALLS & SNYDER LLC Reduces Stake in Omeros Corp: A Strategic Portfolio Adjustment
GuruFocus News • 5:54am
Feb 20, 2025
Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA
Business Wire • 9:00am
Feb 14, 2025
Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings
Business Wire • 9:00am
Feb 10, 2025
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
Business Wire • 9:00am
Jan 16, 2025
Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
Business Wire • 9:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news